Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W CLARKE

Showing results (751-760 of 856) with videos related to

Pageof 86
Sort By:
JACC. Cardiooncology|August 16, 2021
Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer: The PRONOUNCE Trial Study DesignChiara Melloni, Susan F Slovin, Allan Blemings, et al.
The Journal of Pathology|September 2, 2003
Applications of Fourier transform infrared microspectroscopy in studies of benign prostate and prostate cancer. A pilot studyE Gazi, J Dwyer, P Gardner, et al.
American Journal of Clinical Oncology|August 5, 2009
Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasisJames W Clarke, Steven Register, John M McGregor, et al.
The Annals of Thoracic Surgery|November 14, 2018
Cognition and Cerebral Infarction in Older Adults After Surgical Aortic Valve ReplacementTania Giovannetti, Catherine C Price, Molly Fanning, et al.
Familial Cancer|June 27, 2019
Multiple primary malignancies associated with a germline SMARCB1 pathogenic variantJudith A Eelloo, Miriam J Smith, Naomi L Bowers, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2024
Fulfilling the Promise of Breathomics: Considerations for the Discovery and Validation of Exhaled Volatile BiomarkersPaul Brinkman, Michael Wilde, Waqar Ahmed, et al.
The Lancet. Oncology|September 5, 2022
Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trialFred Saad, Antoine Thiery-Vuillemin, Pawel Wiechno, et al.
The European Respiratory Journal|October 26, 2007
Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjectsR A Brown, G W Clarke, C L Ledbetter, et al.
BJU International|November 8, 2008
Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trialNicholas D James, Matthew R Sydes, Noel W Clarke, et al.
BJU International|July 31, 2025
Preferences between three options for androgen deprivation therapy: a focus group studyHannah L Rush, Sophie Merrick, John Marshall, et al.
Pageof 86

Showing results (751-760 of 856) with videos related to

Sort By:
Pageof 86
JACC. Cardiooncology|August 16, 2021
Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer: The PRONOUNCE Trial Study DesignChiara Melloni, Susan F Slovin, Allan Blemings, et al.
The Journal of Pathology|September 2, 2003
Applications of Fourier transform infrared microspectroscopy in studies of benign prostate and prostate cancer. A pilot studyE Gazi, J Dwyer, P Gardner, et al.
American Journal of Clinical Oncology|August 5, 2009
Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasisJames W Clarke, Steven Register, John M McGregor, et al.
The Annals of Thoracic Surgery|November 14, 2018
Cognition and Cerebral Infarction in Older Adults After Surgical Aortic Valve ReplacementTania Giovannetti, Catherine C Price, Molly Fanning, et al.
Familial Cancer|June 27, 2019
Multiple primary malignancies associated with a germline SMARCB1 pathogenic variantJudith A Eelloo, Miriam J Smith, Naomi L Bowers, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2024
Fulfilling the Promise of Breathomics: Considerations for the Discovery and Validation of Exhaled Volatile BiomarkersPaul Brinkman, Michael Wilde, Waqar Ahmed, et al.
The Lancet. Oncology|September 5, 2022
Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trialFred Saad, Antoine Thiery-Vuillemin, Pawel Wiechno, et al.
The European Respiratory Journal|October 26, 2007
Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjectsR A Brown, G W Clarke, C L Ledbetter, et al.
BJU International|November 8, 2008
Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trialNicholas D James, Matthew R Sydes, Noel W Clarke, et al.
BJU International|July 31, 2025
Preferences between three options for androgen deprivation therapy: a focus group studyHannah L Rush, Sophie Merrick, John Marshall, et al.
Pageof 86